which glp 1 is best for kidney disease GLP-1 drugs may extend life, graft survival transplant recipients with diabetes GLP-1s and Kidney Disease​: Benefits

(*Together with Shriners Childrens Northern California) Ranked Sacramentos #1 hospital by U.S

85 US National Institutes of Health

It is not magic, and it is not the whole plan

Weight loss goals are now disease-driven, not cosmetic 5% minimum meaningful benefit 10% required for most metabolic conditions 15% often needed for OSA, HFpEF, MASH, and severe obesity Medication choice is guided by comorbidities GLP-1 receptor agonists and dual GIP/GLP-1 agents are prioritized in patients with: Prediabetes & type 2 diabetes ASCVD Heart failure with preserved EF Metabolic liver disease Obstructive sleep apnea Cardiovascular outcomes now matter Semaglutide 2.4 mg demonstrated a significant reduction in major cardiovascular events even in people without diabetes